Damiani, D <br/><br/>
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.  [electronic resource] 

 -  Leukemia  Aug 1998 
 - 1236-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2401092  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bilirubin--blood<br/>Chemotherapy, Adjuvant<br/>Creatinine--blood<br/>Cyclosporine--adverse effects<br/>Cytarabine--administration & dosage<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Idarubicin--administration & dosage<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Treatment Outcome